Halozyme Therapeutics (HALO)
(Delayed Data from NSDQ)
$38.46 USD
-0.66 (-1.69%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $38.49 +0.03 (0.08%) 7:20 PM ET
3-Hold of 5 3
B Value B Growth C Momentum A VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/7/24 |
---|---|
Current Quarter | 0.69 |
EPS Last Quarter | 0.82 |
Last EPS Surprise | 0.00% |
ABR | 1.40 |
Earnings ESP
|
-5.80% |
---|---|
Current Year | 3.68 |
Next Year | 4.52 |
EPS (TTM) | 2.78 |
P/E (F1) | 10.65 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 201.72M | 205.86M | 954.35M | 1.11B |
# of Estimates | 5 | 5 | 5 | 6 |
High Estimate | 221.64M | 223.72M | 966.56M | 1.20B |
Low Estimate | 187.71M | 195.60M | 948.52M | 1.08B |
Year ago Sales | 162.14M | 221.04M | 829.25M | 954.35M |
Year over Year Growth Est. | 24.41% | -6.87% | 15.09% | 15.96% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.69 | 0.73 | 3.68 | 4.52 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | 0.63 | 0.69 | 3.67 | 4.21 |
High Estimate | 0.77 | 0.80 | 3.77 | 4.67 |
Low Estimate | 0.63 | 0.69 | 3.55 | 4.21 |
Year ago EPS | 0.47 | 0.74 | 2.77 | 3.68 |
Year over Year Growth Est. | 46.81% | -1.35% | 32.85% | 22.96% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 2 | 1 | 1 |
Down Last 60 Days | 3 | 3 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.69 | 0.73 | 3.68 | 4.52 |
7 Days Ago | 0.69 | 0.73 | 3.68 | 4.51 |
30 Days Ago | 0.75 | 0.79 | 3.67 | 4.53 |
60 Days Ago | 0.77 | 0.81 | 3.67 | 4.46 |
90 Days Ago | 0.86 | 0.91 | 3.65 | 4.24 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.65 | 0.70 | 3.69 | 4.40 |
Zacks Consensus Estimate | 0.69 | 0.73 | 3.68 | 4.52 |
Earnings ESP | -5.80% | -4.80% | 0.41% | -2.77% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.82 | 0.75 | 0.74 | 0.47 | NA |
Estimate | 0.82 | 0.71 | 0.63 | 0.48 | NA |
Difference | 0.00 | 0.04 | 0.11 | -0.01 | 0.04 |
Surprise | 0.00% | 5.63% | 17.46% | -2.08% | 5.25% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more